Immunogenicity and Safety of Group A, C, Y and W135 Meningococcal Polysaccharide Vaccine
Clinical trial NCT02003313 · COMPLETED
Trial details
- NCT number
- NCT02003313
- Sponsor
- Beijing Minhai Biotechnology Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2015-05-01
- Enrollment
- 1260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.